Huiying Yu
Number 600 Tianhe Road
Guangzhou, 510630, China
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss.
Journal: Virology journal
Published: May 31, 2025
Predictive value of soluble PD-1 for HBsAg loss in HbeAg-negative patients with chronic hepatitis B: results from a prospective study.
Journal: Hepatology international
Published: February 07, 2025
Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss.
Journal: Virology journal
Published: January 11, 2025
Synergistic activity of menadione in combination with colistin against colistin-susceptible and colistin-resistant Gram-negative bacteria.
Journal: International journal of antimicrobial agents
Published: December 25, 2024
SLC22A1 Resists Hepatitis B Virus by Activating the JAK/STAT Pathway and Predicts the Effect of Pegylated Interferon α-Based Therapy on Chronic Hepatitis B.
Journal: The Journal of infectious diseases
Published: October 16, 2024
Occurrence and characterization of NDM-5-producing Escherichia coli from retail eggs.
Journal: Frontiers in microbiology
Published: August 23, 2023
First detection of tet(X4)-positive Enterobacterales in retail vegetables and clonal spread of Escherichia coli ST195 producing Tet(X4) in animals, foods, and humans across China and Thailand.
Journal: International journal of food microbiology
Published: November 11, 2022
Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon-based therapy.
Journal: Journal of viral hepatitis
Published: April 26, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026